info@targetmol.com    Tel: (857) 239-0968 / (617) 419-7131
Home > Others > Signaling pathway-Others > PBTZ169
PBTZ169  
Catalog No. T3583    CAS 1377239-83-2
Pack Size
Availability
Price/USD
Quantity
5mg
In Stock
110.00
10mg
In Stock
175.00
25mg
In Stock
350.00
50mg
In Stock
560.00
100mg
In Stock
810.00
10mM * 1mL (in DMSO)
In Stock
120.00
Bulk Size: Please Quote for Discount
Documents and Quality Management
Purity:99.00% COA Datasheet HNMR
Biological Activity:

Product Description:

PBTZ169 is a new drug candicate that inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043

Target:
There are currently no data!
Research Area:
Respiratory system/ Immunology system
Chemical Information:
Molecular Weight 456.48
Formula C20H23F3N4O3S
CAS Number 1377239-83-2
Solubility DMSO: 6.4 mg/mL (Need ultrasonic)
Storage 3 years -20°C powder;
2 years -80°C in solvent;
Remark For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.
Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Related Compound Libraries
This product is contained In the following compound libraries:
  • The compound is not included in our libraries at this moment.
Product Recommendations
  • GLPG1690, GLPG-1690, a first-in-class autotaxin inhibitor, currently being evaluated in an exploratory phase 2...
  • BTZ043, BTZ043 is a inhibitor of decaprenyl-phosphoribose-epimerase (DprE1), It can display nanomolar bacter...
  • GAL-021, GAL-021 a new intravenous BKCa-channel blocker.
  • NIH-12848, NIH-12848 is a putative phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) inhibitor with an IC50...
  • Exp3174, EXP-3174 is a potent AT1 antagonist (Kis = 0.57 and 0.67 nM for rat and human forms, respectively), ...

 

Reference

If you have additional questions, Please send us a message. * Required